Centers for Medicare & Medicaid Services has proposed a near zero increase in Medicare Advantage payments, affecting growth ...

Medicare Advantage members in value-based care arrangements had 24.3% fewer inpatient hospital admissions than those in Original Medicare in 2024. Humana Medicare Advantage members receiving ...

Morgan Stanley flagged a new Medicare Advantage policy overhang, saying Humana’s "disproportionate" exposure could pressure ...

Shares of large Medicare plan providers Humana, CVS Health and UnitedHealth Group plunged in extended trading.

A federal proposal targeting Medicare Advantage payments sent Louisville-based Humana’s stock down about 20% Tuesday and ...

That 91.1% benefit ratio is harsh. For context, anything above 90% offers very scant opportunities for profitability.

Humana Inc. (NYSE:HUM) is one of the noteworthy S&P 500 stocks Jim Cramer highlighted. Cramer highlighted what caused an instant sell-off in companies like Humana and others that had exposure to ...

Humana stock plunged 21% after a shockingly low Medicare Advantage rate proposal threatens margins and clouds the insurer’s outlook.

Humana's stock has declined 18% while the S&P 500 returned 13.5%, driven by short-term issues with Medicare Advantage. Despite short-term cost challenges, Medicare Advantage remains a long-term ...

On October 14, 2025, Humana faced a legal setback when U.S. District Judge Reed O’Connor ruled against the company in its challenge to the Medicare Advantage Star Ratings. The Centers for Medicare & ...

Humana is one of the many Medicare-approved private insurance companies that offer Medicare Advantage (Part C) plans. These plans are an alternative to Original Medicare (Part A and Part B) plans.